US Federal 2025-2026 Regular Session

US Federal House Bill HB1064

Introduced
2/6/25  

Caption

Stopping Overdoses of Fentanyl Analogues ActThis bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires March 31, 2025.

Impact

If enacted, HB1064 will impact federal drug enforcement policies by enabling stringent control over fentanyl analogs, thus facilitating law enforcement's ability to combat the rising epidemic of fentanyl overdoses and substance abuse. By treating fentanyl-related substances analogously to existing Schedule I drugs, the bill provides a legal mechanism to prosecute manufacturers and distributors of these substances more effectively. Furthermore, it represents a proactive approach to drug regulation, aiming to reduce the circulation of potentially dangerous synthetic opioids that have been linked to high rates of overdose fatalities across the country.

Summary

House Bill 1064, officially titled the 'Stopping Overdoses of Fentanyl Analogues Act,' seeks to amend the Controlled Substances Act by designating fentanyl-related substances as Schedule I controlled substances. This classification includes various modifications of fentanyl and aims to enhance the regulatory framework surrounding substances that are structurally related to fentanyl, which has become a significant concern in the ongoing opioid crisis. The bill proposes a comprehensive definition of fentanyl-related substances to ensure that a wider array of synthetic opioids can be controlled under federal law, thereby addressing the emergence of new analogues that pose risks to public health.

Contention

There are notable points of contention regarding the bill's implications for drug regulation and enforcement. Critics argue that while the intention behind HB1064 is to curtail the opioid crisis, it may inadvertently restrict access to legitimate medications that are critical for patients managing pain. Additionally, concerns have been raised about the potential for overreach in regulations, affecting researchers and manufacturers of pharmaceuticals containing controlled substances. Balancing the need for effective control against the possible negative effects on medical research and patient access remains a key debate as discussions around this legislation progress.

Congress_id

119-HR-1064

Policy_area

Crime and Law Enforcement

Introduced_date

2025-02-06

Companion Bills

No companion bills found.

Previously Filed As

US S1865

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

US A4494

Adds illicit fentanyls to Schedule I in the "New Jersey Controlled Dangerous Substances Act."

US HB2365

Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.

US HB2765

Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substance.

US HB2804

CONTROLLED SUBSTANCES-FENTANYL

US SB0280

CONTROLLED SUBSTANCES-FENTANYL

US HB1162

Add certain substances to Schedule I of the controlled substances schedule.

US LB72

Change provisions relating to controlled substances schedules under the Uniform Controlled Substances Act

US SB497

Adding kratom to schedule I of the uniform controlled substances act and making conforming amendments to the definition of fentanyl-related controlled substance in the criminal code.

US HB3767

Controlled dangerous substances; adding certain substances to Schedules I and IV; effective date.

Similar Bills

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MA H2227

Replacing archaic and stigmatizing language for substance use

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

MI HB4167

Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

MI HB4256

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25

MI SB0431

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25